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Background: Untreated severe aortic stenosis (AS) is associated with a high morbidity and mortality. A recent study of a claims database 
revealed women with aortic disease were half as likely as men to undergo aortic valve replacement (AVR), however severity of aortic disease was not 
assessed. Our aim was to determine operative rates and time to surgery in men versus women with severe AS.
Methods: Our center’s echocardiography database was used to identify all adult patients (pts) with severe AS in the year 2005. Baseline 
characteristics including time of initial diagnosis of severe AS, symptoms, valve assessment, and co-morbidities, as well as treatment and survival 
outcomes were obtained. Multivariable logistic regression was performed to assess probability of undergoing AVR in men vs women. To assess time to 
surgery, a 6 month landmark analysis was performed to exclude pts followed at outside institutions referred solely for surgery.
Results: 237 pts were identified with severe AS (54% women). The overall operative rate for the cohort was 67%. After adjusting for age, mortality 
was significantly improved in both men and women undergoing AVR when compared to pts not undergoing AVR (Cox HR 0.34, p<0.001). 58% of 
women underwent AVR vs 78% of men. Men were 35% more likely to undergo AVR than women (RR 1.35, 95% CI 1.13-1.61, Fisher’s exact p = 
0.001). After correcting for age, symptoms, heart failure class, co-morbidities, left ventricular ejection fraction, and aortic valve area and gradients, 
the odds of women not undergoing AVR were 5.3-fold higher than men (logistic regression, p < 0.01). In the landmark analysis of pts operated on at 
least 6 months after diagnosis with severe AS, women waited 3.3 years vs 2.2 years for men (p = 0.032). This was statistically significant even after 
adjusting for age, symptoms, creatinine, ejection fraction, aortic valve index and gradient (p = 0.041).
Conclusions: In this single center analysis of patients with severe AS, women were significantly less likely to undergo AVR than men. Women who 
underwent AVR waited an average of 1.1 years longer than men between initial diagnosis and surgery.
